Scientists Uncover Shocking Flaws: Investigation Questions Effectiveness of Popular Anti-Platelet Drug
Ticagrelor costs the United States over $750 million annually, yet a BMJ investigation casts new doubts on the reliability of the pivotal clinical trial that led to the drug’s approval.…